NEW YORK and SEOUL, South Korea – The Juvenile Diabetes Research Foundation is partnering with EOFlow Co., Ltd. to develop a wearable, disposable automated insulin delivery patch device for people with Type 1 diabetes.
EOFlow recently received Korean Ministry of Food and Drug Safety approval on its wearable insulin pump system, the EOPatch, which incorporates a proprietary electroosmotic pumping technology that makes it small and light. The company will work with the JDRF to create a device suitable for children.
“Innovation in automated insulin delivery devices and artificial pancreas systems will help to significantly improve health and quality of life for people with T1D,” said Jaime Giraldo, a research scientist at the JDRF, in a statement. “Next-generation wearable designs that are smaller and employ user-centric design will remove barriers that prevent some people, especially small children, from using these life-saving and life-changing glucose management devices.”
EOFlow will use funding from the partnership to develop and run clinical studies on the wearable device, which consists of an insulin pump and an integrated continuous glucose sensor that is run by a closed-loop program that autonomously regulates the blood glucose level with minimal user input.
The partnership marks the first time JDRF is granting funds to EOFlow for research and is also the first time that JDRF is funding a company in Korea.